Krzysztof L.
- Country
- Poland
- Department
- N/A
Research Overview
- Efficacy and Safety Evaluation of Atuliflapon in Adults with Moderate-to-Severe Uncontrolled Asthma: A Phase 2a Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of Amikacin Liposome Inhalation Suspension with Azithromycin and Ethambutol in Adult Patients with MAC-Induced NTM Lung Infection
- Efficacy and Safety Evaluation of Astegolimab in Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study
Data & Insights
Has run more than one trial at 19 of 184 partner sites.
Specializations
Respiratory Infections
The investigator specializes in treating nontuberculous mycobacterial lung infections, particularly those caused by Mycobacterium avium Complex (MAC). Their research encompasses innovative therapeutic approaches using liposomal drug delivery systems.
- MAC lung infections
- Inhaled antimicrobial therapy
- Liposomal drug formulations
Chronic Respiratory Conditions
The investigator focuses on advanced treatments for Chronic Obstructive Pulmonary Disease (COPD), exploring both novel biological therapies and combination inhaler treatments. Their work addresses acute exacerbations and cardiopulmonary outcomes.
- COPD exacerbation management
- Triple therapy approaches
- Bronchodilator combinations
Inflammatory Airway Disease
The investigator conducts research in moderate to severe uncontrolled asthma, investigating new therapeutic agents for better disease control. Their work focuses on novel oral treatments for asthma management.
- Uncontrolled asthma
- Oral asthma therapeutics
- Inflammatory pathway modulation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.